Global Vulvar and Vaginal Atrophy Therapy Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028
Report Code: KNJ1056777 No. of Pages: 129 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Vulvar and Vaginal Atrophy Therapy market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.
This report studies the Vulvar and Vaginal Atrophy Therapy market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Vulvar and Vaginal Atrophy Therapy in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Vulvar Atrophy Therapy
Vaginal Atrophy Therapy
Market Snapshot, By Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others
Main Market Players Analyzed in this report, including:
Viveve
VenusConcept
ThermiGen LLC
Lutronic
Hologic
Fotona
BTL Group of Companies
Almirall
Alma Lasers
The study objectives of this report are:
To study and analyze the global Vulvar and Vaginal Atrophy Therapy market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Vulvar and Vaginal Atrophy Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Vulvar and Vaginal Atrophy Therapy manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vulvar and Vaginal Atrophy Therapy market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Vulvar and Vaginal Atrophy Therapy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Vulvar and Vaginal Atrophy Therapy are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Vulvar and Vaginal Atrophy Therapy Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Vulvar and Vaginal Atrophy Therapy Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Vulvar and Vaginal Atrophy Therapy
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Vulvar and Vaginal Atrophy Therapy Sales Channel and Distributors Analysis
3.3.1 Vulvar and Vaginal Atrophy Therapy Sales Channel
3.3.2 Vulvar and Vaginal Atrophy Therapy Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Hospitals
3.4.2 Major Buyers in Ambulatory Surgical Centers
3.5 Vulvar and Vaginal Atrophy Therapy Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Vulvar and Vaginal Atrophy Therapy Type Introduction
4.1.1 Vulvar Atrophy Therapy
4.1.2 Vaginal Atrophy Therapy
4.2 Global Vulvar and Vaginal Atrophy Therapy Sales by Type 2016-2021
4.3 Global Vulvar and Vaginal Atrophy Therapy Revenue by Type 2016-2021
4.4 Global Vulvar and Vaginal Atrophy Therapy Price by Type 2016-2021
5 Market Segment: by Application
5.1 Vulvar and Vaginal Atrophy Therapy Type Introduction
5.1.1 Hospitals
5.1.2 Ambulatory Surgical Centers
5.1.3 Specialty Clinics
5.1.3 Others
5.2 Global Vulvar and Vaginal Atrophy Therapy Sales by Application 2016-2021
5.3 Global Vulvar and Vaginal Atrophy Therapy Revenue by Application 2016-2021
5.4 Global Vulvar and Vaginal Atrophy Therapy Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Vulvar and Vaginal Atrophy Therapy Market by Region
6.1.1 Global Vulvar and Vaginal Atrophy Therapy Sales by Regions
6.1.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Regions
6.2 North America Vulvar and Vaginal Atrophy Therapy Market 2016-2021
6.3 Europe Vulvar and Vaginal Atrophy Therapy Market 2016-2021
6.4 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market 2016-2021
6.5 South America Vulvar and Vaginal Atrophy Therapy Market 2016-2021
6.6 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market 2016-2021
7 North America
7.1 North America Vulvar and Vaginal Atrophy Therapy Market by Country 2016-2021
7.1.1 North America Vulvar and Vaginal Atrophy Therapy Sales by Country
7.1.2 North America Vulvar and Vaginal Atrophy Therapy Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Vulvar and Vaginal Atrophy Therapy Market by Country 2016-2021
8.1.1 Europe Vulvar and Vaginal Atrophy Therapy Sales by Country
8.1.2 Europe Vulvar and Vaginal Atrophy Therapy Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Vulvar and Vaginal Atrophy Therapy Market by Country 2016-2021
9.1.1 Asia Pacific Vulvar and Vaginal Atrophy Therapy Sales by Country
9.1.2 Asia Pacific Vulvar and Vaginal Atrophy Therapy Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Vulvar and Vaginal Atrophy Therapy Market by Country 2016-2021
10.1.1 South America Vulvar and Vaginal Atrophy Therapy Sales by Country
10.1.2 South America Vulvar and Vaginal Atrophy Therapy Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Market by Country 2016-2021
11.1.1 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Sales by Country
11.1.2 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Viveve
12.1.1 Viveve
Company Information
12.1.2 Viveve
Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.1.3 Viveve
Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Viveve
Key Development
12.2 VenusConcept
12.2.1 VenusConcept
Company Information
12.2.2 VenusConcept
Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.2.3 VenusConcept
Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 VenusConcept
Key Development
12.3 ThermiGen LLC
12.3.1 ThermiGen LLC
Company Information
12.3.2 ThermiGen LLC
Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.3.3 ThermiGen LLC
Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 ThermiGen LLC
Key Development
12.4 Lutronic
12.4.1 Lutronic
Company Information
12.4.2 Lutronic
Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.4.3 Lutronic
Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Lutronic
Key Development
12.5 Hologic
12.5.1 Hologic
Company Information
12.5.2 Hologic
Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.5.3 Hologic
Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Hologic
Key Development
12.6 Fotona
12.6.1 Fotona
Company Information
12.6.2 Fotona
Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.6.3 Fotona
Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Fotona
Key Development
12.7 BTL Group of Companies
12.7.1 BTL Group of Companies
Company Information
12.7.2 BTL Group of Companies
Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.7.3 BTL Group of Companies
Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Fotona
Key Development
12.9 Alma Lasers
12.9.1 Alma Lasers
Company Information
12.9.2 Alma Lasers
Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.9.3 Alma Lasers
Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Alma Lasers
Key Development
12.8.1 Almirall
Company Information
12.8.2 Almirall
Vulvar and Vaginal Atrophy Therapy Product Portfolio, Specification and Application
12.8.3 Almirall
Vulvar and Vaginal Atrophy Therapy Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Almirall
Key Development
13 Global Vulvar and Vaginal Atrophy Therapy Market Forecast by Region by Type and by Application
13.1 Global Vulvar and Vaginal Atrophy Therapy Sales, Revenue Forecast 2022-2027
13.2 Global Vulvar and Vaginal Atrophy Therapy Forecast by Regions
13.2.1 Global Vulvar and Vaginal Atrophy Therapy Sales Forecast by Region 2022-2027
13.2.2 Global Vulvar and Vaginal Atrophy Therapy Revenue Forecast by Region 2022-2027
13.3 Global Vulvar and Vaginal Atrophy Therapy Forecast by Type
13.3.1 Global Vulvar and Vaginal Atrophy Therapy Sales Forecast by Type 2022-2027
13.3.2 Global Vulvar and Vaginal Atrophy Therapy Revenue Forecast by Type 2022-2027
13.3.3 Global Vulvar and Vaginal Atrophy Therapy Price Forecast by Type 2022-2027
13.4 Global Vulvar and Vaginal Atrophy Therapy Forecast by Application
13.4.1 Global Vulvar and Vaginal Atrophy Therapy Sales Forecast by Application 2022-2027
13.4.2 Global Vulvar and Vaginal Atrophy Therapy Revenue Forecast by Application 2022-2027
13.4.3 Global Vulvar and Vaginal Atrophy Therapy Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com